Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Comparing the Efficacy and Safety of Apixaban and Warfarin in Patients with Atrial Fibrillation and Advanced Chronic Kidney Disease

Juzer Ali Asgar, Amal Benchakroun, Nicholas Sass, Samar Hassani, Leonard Efuet-Ateh, Harrison Koss, Can Jones, Catherine Ostos, Francisco Alvarado, Robert Chait

Blood (2024) 144 (Supplement 1): 5583.

https://doi.org/10.1182/blood-2024-212201

Published: 2024

Journal Articles

Battle of the Blood Thinners: Unveiling the Impact of Apixaban and Warfarin on GI Bleeding in Advanced Kidney Disease Patients When Used for Management of VTE

Juzer Ali Asgar, Amal Benchakroun, Samar Hassani, Nicholas Sass, Azin Steadman, Anthony Perez, Mariel Duchow, Omar Asad, Can Jones, Catherine Ostos, Francisco Alvarado, Robert Chait

Blood (2024) 144 (Supplement 1): 5585.

https://doi.org/10.1182/blood-2024-212296

Published: 2024

Journal Articles

Transfusion Requirements in Hospitalized Patients with Sickle Cell Disease Taking Either Voxelotor or Hydroxyurea

Virginia Velez Quinones, Catherine Ostos, Mariel Duchow, Kristina Menchaca, Can Jones, Shaun Isaac

Blood (2023) 142 (Supplement 1): 5339.

https://doi.org/10.1182/blood-2023-172571

Published: 2023

Journal Articles

Occurrence and Outcomes of Acute Cerebrovascular Events in Patients with Non-Hodgkin Lymphoma

Catherine Ostos, Virginia Velez Quinones, Kristina Menchaca, Can Jones, Mariel Duchow, Shaun Isaac, Patrick Hardigan

Blood (2023) 142 (Supplement 1): 6137.

https://doi.org/10.1182/blood-2023-188049

Published: 2023

Journal Articles

Outcomes of Thromboembolism in COVID-19 Cancer Patients Vs Non-Cancer Patients

Can Jones, Kristina Menchaca, Catherine Ostos, Jeffery Durbin, Kai Chen, Shachar Peles

Blood (2022) 140 (Supplement 1): 5660.

https://doi.org/10.1182/blood-2022-157218

Published: 2022

NARROW

Comparing the Efficacy and Safety of Apixaban and Warfarin in Patients with Atrial Fibrillation and Advanced Chronic Kidney Disease

Battle of the Blood Thinners: Unveiling the Impact of Apixaban and Warfarin on GI Bleeding in Advanced Kidney Disease Patients When Used for Management of VTE

Transfusion Requirements in Hospitalized Patients with Sickle Cell Disease Taking Either Voxelotor or Hydroxyurea

Occurrence and Outcomes of Acute Cerebrovascular Events in Patients with Non-Hodgkin Lymphoma

Outcomes of Thromboembolism in COVID-19 Cancer Patients Vs Non-Cancer Patients

Email alerts

ASH Publications

American Society of Hematology

Comparing the Efficacy and Safety of Apixaban and Warfarin in Patients with Atrial Fibrillation and Advanced Chronic Kidney Disease

Battle of the Blood Thinners: Unveiling the Impact of Apixaban and Warfarin on GI Bleeding in Advanced Kidney Disease Patients When Used for Management of VTE

Transfusion Requirements in Hospitalized Patients with Sickle Cell Disease Taking Either Voxelotor or Hydroxyurea

Occurrence and Outcomes of Acute Cerebrovascular Events in Patients with Non-Hodgkin Lymphoma

Outcomes of Thromboembolism in COVID-19 Cancer Patients Vs Non-Cancer Patients

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only